Login to Your Account

Takeda Keeps Widening Global Footprint in $250M Multilab Buy

By Jennifer Boggs
Managing Editor

Tuesday, May 29, 2012
Only weeks after disclosing its goal of expanding into emerging markets in its 2012-2014 Mid-Range Plan, Takeda Pharmaceutical Co. Ltd. made a move in Brazil with the acquisition of Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. for BRL500 million (US$249.9 million) up front and up to BRL40 million in future milestones.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription